Eli Lilly’s 340B deadline passes: What hospitals should know

(By: Ella Jeffries for Becker’s Hospital Review)

Eli Lilly’s deadline for hospitals to submit claims data or lose 340B drug discounts has passed, and with HHS’ Health Resources and Services Administration silent on requests from hospital and pharmacy groups to intervene, noncompliant hospitals are exposed. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.